Table 2 : Characteristic physiological parameters associated with the Type 1 diabetes mellitus*, †, ‡.


Group

Items/
Normal range
1 2 3 4 5 6 7 8
CTL AAM QT AAM+QT DM DM+AAM DM+ QT DM+ AAM+ QT

Insulin, (mg/L)(0.5-2.0) 1.4±0.5 1.3±0.4 1.4±0.4 1.4±0.3 0.7±0.3& 0.7±0.3& 0.7±0.4& 0.8±0.1&
Blood sugar mg/dL 185±15 175±10 160±5 225±40 320±45 400±93 421±80 520±57
Urine glucose (mg/dL) 0.0 0.0 0.0 0.0 80±6& 52±7&∂ 43±6&∂ 45±5&∂
BW, g
KW, g
363±7
2.9±0.1
362±6
2.9±0.1
362±8
2.9±0.1
350±8
2.8±0.1
318±6&
3.5±0.2&
292±5&
3.5±0.2&
309±9&
3.4±0.2&
292±6&
3.8±0.2&
KW/BW (%)  0.8±0.1 0.8±0.4 0.7±0.1& 0.8±0.1 1.1±0.3& 1.2±0.4& 1.1±0.1& 1.3±0.2&

*Measured on urine collected the first day after different treatments.
†Data expressed in mean±SD (n = 8).
‡The symbol "&" in the same row indicate significant difference from the normal control (p<0.05). The symbol "∂"
in the same row indicates significant difference among the DM-related groups taking the DM rats as the reference.
Dose: ip Moriamin 1.6 mL/rat-day. QT ip treated control (70 mg/kg-day, suspended in PBS).

Chen et al.Journal of Diabetes Research and Clinical Metabolism  2014 3:5DOI : 10.7243/2050-0866-3-5